Wynne Weston-Davies
No más puestos en curso
Historial de carrera de Wynne Weston-Davies
Antiguos cargos conocidos de Wynne Weston-Davies.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Varleigh Immuno Pharmaceuticals Uk Ltd. | Director Técnico/Científico/I+D | 01/01/2009 | 01/01/2014 |
Evolutec Group Plc
 Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Director Técnico/Científico/I+D | - | - |
Volution Immuno Pharmaceuticals SA
 Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Director Técnico/Científico/I+D | 01/01/2014 | - |
| AKARI THERAPEUTICS, PLC | Director Técnico/Científico/I+D | 01/09/2015 | - |
Estadísticas
Internacional
| Reino Unido | 3 |
| Estados Unidos | 2 |
| Suiza | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AKARI THERAPEUTICS, PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
Volution Immuno Pharmaceuticals SA
Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Health Technology |
| Varleigh Immuno Pharmaceuticals Uk Ltd. | |
Evolutec Group Plc
Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Wynne Weston-Davies
- Experiencia
